Vigabatrin (γ-vinyl-GABA), an irreversible GABA-T inhibitor, was developed in the 1970s and has since become an established treatment for specific epilepsy syndromes, particularly infantile spasms (West syndrome) and refractory complex partial seizures [20,21]. The gene discussed is ABAT; the disease is infantile spasms.